Concepedia

Pieter Busschaert

PB

3

Publications

106

Citations

3

H-Index

2018

Active since

Affiliations

KU Leuven(Current)

VIB-KU Leuven Center for Cancer Biology

Pieter Busschaert is an author at KU Leuven specializing in cancer therapeutics, radiation oncology, and gynecology oncology.

Top concepts

Publications per year

2018–2022

3

Publications

3

Randomized phase II CLIO study on olaparib monotherapy versus chemotherapy in platinum-resistant ovarian cancer.

Adriaan Vanderstichele, Els Van Nieuwenhuysen, Sileny Han et al. · Journal of Clinical Oncology · 2019 · 40 citations

, , +15

Ischemia-Induced DNA Hypermethylation during Kidney Transplant Predicts Chronic Allograft Injury

Line Heylen, Bernard Thienpont, Maarten Naesens et al. · Journal of the American Society of Nephrology · 2018 · 38 citations · Full text

Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer

Adriaan Vanderstichele, Liselore Loverix, Pieter Busschaert et al. · Gynecologic Oncology · 2022 · 28 citations

, , +8

Rows per page

1–3 of 3